Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haynes

Showing results (451-460 of 843) with videos related to

Pageof 85
Sort By:
Journal of Virology|August 21, 2020
Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry InhibitorS Munir Alam, Kenneth Cronin, Robert Parks, et al.
AIDS (London, England)|December 17, 2010
Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African populationSlavé Petrovski, Jacques Fellay, Kevin V Shianna, et al.
Clinical and Vaccine Immunology : CVI|January 29, 2011
Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgAJin Qiu, Lin Yan, Jianbo Chen, et al.
Nature Communications|May 15, 2023
Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineageRory Henderson, Ye Zhou, Victoria Stalls, et al.
Journal of Virology|May 22, 2015
Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 TransmissionRandi B Gombos, Dror Kolodkin-Gal, Leila Eslamizar, et al.
Journal of Virological Methods|April 10, 2007
High throughput functional analysis of HIV-1 env genes without cloningJennifer L Kirchherr, Xiaozhi Lu, Webster Kasongo, et al.
Cell Host & Microbe|June 5, 2018
Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody DevelopmentKevin Wiehe, Todd Bradley, R Ryan Meyerhoff, et al.
NPJ Vaccines|May 16, 2020
Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaquesMaria Blasi, Elizabeth C Wescott, Erich J Baker, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicitySophie M-C Gobeil, Katarzyna Janowska, Shana McDowell, et al.
Nature Structural & Molecular Biology|July 24, 2020
Controlling the SARS-CoV-2 spike glycoprotein conformationRory Henderson, Robert J Edwards, Katayoun Mansouri, et al.
Pageof 85

Showing results (451-460 of 843) with videos related to

Sort By:
Pageof 85
Journal of Virology|August 21, 2020
Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry InhibitorS Munir Alam, Kenneth Cronin, Robert Parks, et al.
AIDS (London, England)|December 17, 2010
Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African populationSlavé Petrovski, Jacques Fellay, Kevin V Shianna, et al.
Clinical and Vaccine Immunology : CVI|January 29, 2011
Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgAJin Qiu, Lin Yan, Jianbo Chen, et al.
Nature Communications|May 15, 2023
Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineageRory Henderson, Ye Zhou, Victoria Stalls, et al.
Journal of Virology|May 22, 2015
Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 TransmissionRandi B Gombos, Dror Kolodkin-Gal, Leila Eslamizar, et al.
Journal of Virological Methods|April 10, 2007
High throughput functional analysis of HIV-1 env genes without cloningJennifer L Kirchherr, Xiaozhi Lu, Webster Kasongo, et al.
Cell Host & Microbe|June 5, 2018
Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody DevelopmentKevin Wiehe, Todd Bradley, R Ryan Meyerhoff, et al.
NPJ Vaccines|May 16, 2020
Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaquesMaria Blasi, Elizabeth C Wescott, Erich J Baker, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicitySophie M-C Gobeil, Katarzyna Janowska, Shana McDowell, et al.
Nature Structural & Molecular Biology|July 24, 2020
Controlling the SARS-CoV-2 spike glycoprotein conformationRory Henderson, Robert J Edwards, Katayoun Mansouri, et al.
Pageof 85